Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three leading pulmonary hypertension (PH) experts and is designed to keep healthcare professionals on top of the most recent clinical findings.

New information is constantly being learned about the management of patients with PH. Pulmonary Hypertension Due to Interstitial Lung Disease (PH-ILD) represents a complex condition which now has a recently approved inhaled therapy to improve exercise ability. Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but treatable complication of PE, which is often indistinguishable from pulmonary arterial hypertension (PAH). All patients with PH benefit from intensive, continuous clinical monitoring either in person or remotely to guide escalation of treatments. PH remains a disease with poor outcomes, necessitating early diagnosis and appropriate intervention. Improvements in survival and care depends on improving clinician awareness of the latest research and perspectives. This activity brings cutting-edge research to busy clinicians enabling them to readily keep abreast of emerging published research as it relates to the management of PH.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during the 24th International AIDS Conference.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from April through June of 2022 will discuss the most clinically relevant information regarding HIV Epidemiology and Prevention, Treatment-Experienced Patients and Pregnancy and Non-ART.

Activity Summary:
Recognizing and discussing significant developments and strategies in ART places healthcare professionals at the forefront of HIV care. In addition, new frontiers for HIV therapy continue to be explored, as underscored by the clinical development of long-acting regimens and first-in-class antiretroviral agents.

This activity will provide a discussion-based format, from an innovative HIV clinic, to discuss the advantages and limitations of current ART, the implementation of new ART classes/formulations, and the impact new drugs/formulations have on ART management.

Activity Summary:
Learning from Success highlights key, successful strategies to incorporating new ART treatment and prevention options successfully into practice. This discussion based, video presentation will take you directly inside innovative and proven clinics that are involved in providing cutting-edge care to patients with HIV. The first video will focus on an innovative treatment clinic to discuss HIV treatment strategies; the second will focus on a clinic that spearheads HIV prevention services. Several care providers at each clinic will be interviewed and discuss scenarios on how to successfully incorporate new strategies and options for the prevention and treatment of HIV.

Please click on your preferred topic to view each series of episodes. Each activity’s duration will be approximately one hour total. Each one-hour video will be broken into shorter chapters for easier viewing. Video and audio-only files as well as PowerPoint slides are available for downloading.

Activity Summary:

This program will use a case-based format that incorporates the patient voice to discuss patient treatment concerns, translatability of recent study results to clinical practice, and management strategies to improve patient outcomes.

As our understanding of HIV and HIV therapy progress, so do our management approaches. Learning about concerns/barriers that patients with HIV face can lead to improved individualized outcomes as well as place the healthcare professional at the forefront of HIV care.

Activity Summary:
This accredited continuing education webcast archive was presented by HIV specialists who practice in the Southern United States. Geographically appropriate topics and practical strategies within the adolescent population such as ending the HIV epidemic, assessing sexual risk behaviors, and HIV prevention/treatment considerations are discussed.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Through patient cases, Sonja Bartolome, MD, FCCP and Dunbar Ivy, MD provide learners with the opportunity to enhance clinical decision-making skills about the diagnosis and management of PAH. This on-demand presentation will take the learner through a complete virtual patient tour starting at the time of symptoms of PAH through diagnosis, evaluation, and how the disorder is managed. In Case 1, Dr. Bartolome presents how to manage the complications and precautions in a patient through pregnancy, labor and delivery, and the immediate postpartum period. In Case 2, Dr. Ivy presents the common features of pediatric PAH with adult disease including the challenges that require unique approaches.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Over the past two decades, research has vastly improved the understanding of the pathophysiology, diagnosis and treatment of PAH. While no therapies have been approved to target new mechanisms of action in more than 5 years, several phase 2 and phase 3 clinical trials of novel targets have begun. Improvements in the care of PAH patients depends on improving clinician awareness of the latest research into new diagnostic techniques, medications, and monitoring. This slide kit brings cutting-edge research to busy clinicians enabling them to readily keep abreast of the published research.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of certified AMA/ANCC/ACPE enduring videos will spotlight the latest advances in the management of bladder cancer through a series of ‘what you need to know’ videos featuring a leading expert reporting from the 2022 ASCO Annual Meeting.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of certified AMA/ANCC/ACPE enduring videos will spotlight the latest advances in the management of lung cancer treated with targeted therapy through a series of ‘what you need to know’ videos featuring a leading expert reporting from the 2022 ASCO Annual Meeting.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of video highlights will cover bladder cancer and targeted therapy in lung cancer based on data presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Activity Summary:
The Clinical Viewpoints Hereditary Angioedema lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slides developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Hereditary angioedema (HAE) is a potentially life-threatening genetic condition that presents many unique challenges. The diagnosis of HAE is based on suggestive clinical history and physical findings. In addition, optimal management relies on a patient-centered and shared decision-making approach despite the recent significant advances in treatment options. This activity uses a case-based approach to discuss new and existing diagnostic approaches, options for on-demand medications, and individualized strategies for long-term management.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Clinical Viewpoints Hereditary Angioedema lecture library includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert faculty. The slides will be continuously evaluated and updated for current relevance.

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in San Francisco, California, May 13-18, 2022 through a series of two ‘What You Need to Know in 5-minutes’ videos.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Outpatient management of PAH requires unique and practical considerations. Further management decisions regarding emerging therapies, chronic anti-coagulation therapy, exercise recommendations, travel considerations, medication adherence, adverse events and psychosocial issues must also be addressed. This slide kit is designed for the multi-disciplinary medical team to address the practical challenges of managing PAH.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Through patient cases, Usha Krishnan, MD, DM, FAHA and Nicholas Hill, MD discuss the key considerations to manage patients with pulmonary arterial hypertension (PAH). In Case 1, Dr. Krishnan presents the patient with underlying cardiac defects and repair history and lifelong management in multidisciplinary specialty centers with expertise in pulmonary arterial hypertension - congenital heart disease (PAH-CHD). In Case 2, Dr. Hill discusses how to manage the patient with acute right ventricle (RV) failure.

Activity Summary:

New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from January through March of 2022 will discuss the most clinically relevant information regarding PrEP, HIV cure, treatment experienced patients, long-acting ART and comorbidities.

Activity Summary:
We are pleased to have recently held the Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXX (OPMAN). The conference took place March 26-27, 2022, in Orlando, Florida with 15 leading clinicians and researchers presenting an array of topics covering HIV disease and liver disease. The presentations offered a unique distillation of clinically focused data tailored for practicing HIV and hepatitis healthcare professionals.

These accredited enduring video archives of OPMAN XXX provide access to each day of the conference, including clinical presentations, interactive case discussions, and panel discussions addressing audience questions. CME/CE credit is provided separately by section so you can participate in only those sections of interest to you. We hope you enjoy this activity.

Activity Summary:
The Simply Speaking HIV Prevention lecture series includes a curriculum that highlights the very latest clinical data utilizing a PowerPoint slide presentation developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

One key strategy for ending the HIV epidemic in the United States is the rapid and large scale-up of pre-exposure prophylaxis (PrEP) provision by clinicians providing health care to HIV-uninfected persons at risk for HIV acquisition. Current recommendations encourage informing all sexually active adults and adolescents about PrEP, as well as offering PrEP to those at substantial risk of HIV acquisition. This activity will discuss the impact of PrEP on ending the HIV epidemic, benefits and limitations of new and future PrEP options, and strategies to improve sustainable implementation of PrEP.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Patients seen in a typical rheumatology practice are at higher risk of PAH secondary to their conditions. Rheumatologists should maintain a high index of suspicion for PAH in their patients with systemic sclerosis and other mixed connective tissue disorders. Emerging evidence suggests that two of the most prevalent CTDs, systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), should be regarded as separate diseases due to their different etiologies, prognoses, and therapeutic responses. This slide kit will present insights into the different pathophysiological processes and management of patients with SSc and SLE-PAH, as well as recommendations for routine screening, risk factors, diagnosis, management, and ongoing monitoring of patients in a rheumatology practice for PAH.

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Patient-focused care is the core of contemporary management of HIV. Understanding patient challenges as well as listening and learning about their concerns/barriers can improve HIV care outcomes and expectations. This case-based program will incorporate the patient voice into HIV management approaches for metabolic and cardiovascular comorbidities, long-term ART strategies, and transgender persons.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Management lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

The state-of-the-art approach to HIV management continues to evolve as regular advances in basic science and clinical research lay the foundation for future trends. This program provides a forum for discussion of current controversies in the field, including vaccines and HIV, long-term HIV management, weight/metabolic considerations with ART, what antiretrovirals to select for women, and other hot topics in HIV clinical management.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Simply Speaking HIV Management lecture library includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert faculty. The slides will be continuously evaluated and updated for current relevance.

Activity Summary:
Clinical Viewpoints HLH includes a curriculum that highlights the very latest clinical data in Hemophagocytic Lymphohistiocytosis (HLH). Slides are developed and updated throughout the year by leading HLH expert physicians. The Lecture Library offers various topics that can be accessed for AMA or ANCC credit. Review the content and complete the pre- and post-tests and evaluation to receive your credit.

HLH is an aggressive and life-threatening syndrome of excessive immune activation. In persons with HLH, timely diagnosis and appropriate treatment are essential to achieving a successful outcome. This activity will utilize case-based scenarios to review the diverse clinical presentations of suspected HLH, time-efficient approaches for diagnosis, and considerations for targeted treatment and supportive management strategies. Continue to visit the Lecture Library series throughout 2022 to view updates from new publications and conference updates. All content is reviewed and approved by the Clinical Viewpoints HLH Planning Committee.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Research shows that patients with PAH benefit greatly from early diagnosis and treatment. However, patients often face delays of two years or longer from the onset of symptoms before a definitive diagnosis of PAH is reached. Designed for primary care providers and other non-specialists, this case-based slide kit will cover the basics of the diagnosis of PAH, including discussions of the most-common alternative/incorrect diagnoses received by patients and the importance of early referral.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. The Lecture Library offers various topics that can be accessed for AMA, ANCC or ACPE credit. Select your topic of interest and complete the pre/posttest and evaluation.

Continue to visit the Lecture Library series throughout 2022 to view updates from new publications and conference updates. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know in 5-minutes’ videos virtually from the 2022 Conference on Retroviruses and Opportunistic Infections.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from October through December of 2021 will discuss the most clinically relevant information including COVID-19 in PLWH, guideline updates, HIV management strategies and investigational agents.

Activity Summary:
HBV is a most common causes of liver cirrhosis and HCC. Curing persons with HBV infection remains elusive, despite the availablility of effective antiviral therapy. However, the urgency for an HBV cure remains an active area of research. This program will discuss key research advances in the strategies to HBV cure, pros and cons of withdrawal of therapy, and novel antiviral/immunomodulatory therapies.

Dr. Nezam Afdhal and Dr. Daryl Lau will lead each of the 15-minute segment presentations with downloadable, supporting PowerPoint slides. Each segment will be available for .25 AMA/ANCC/ACPE credit/contact hour based on confirmed participation and the completion of an evaluation and post-test.